CDV与CiE两种方案联合术前化疗治疗晚期儿童神经母细胞瘤的近期疗效观察

冯晨, 唐锁勤, 王建文, 刘英, 杨光

中国当代儿科杂志 ›› 2009, Vol. 11 ›› Issue (12) : 885-887.

PDF(956 KB)
PDF(956 KB)
中国当代儿科杂志 ›› 2009, Vol. 11 ›› Issue (12) : 885-887.
论著·临床研究

CDV与CiE两种方案联合术前化疗治疗晚期儿童神经母细胞瘤的近期疗效观察

  • 冯晨,唐锁勤,王建文,刘英,杨光
作者信息 +

Curative effects of the protocol of CDV combined with CiE as pre-operative chemotherapy in high-risk childhood neuroblastoma

  • FENG Chen, TANG Suo-Qin, WANG Jian-Wen, LIU Ying, YANG Guang
Author information +
文章历史 +

摘要

目的:观察CDV(环磷酰胺+柔红霉素+长春新碱)与CiE(顺铂+足叶乙甙)联合术前化疗治疗晚期神经母细胞瘤患儿的近期疗效及相关毒性。方法:回顾分析27例IV期神经母细胞瘤患儿临床资料,年龄1岁2个月至8岁,原发部位腹部21例,后纵隔4例,盆腔2例,骨髓转移23例,多发性骨转移12例。均经CDV方案3疗程及CiE方案2疗程化疗。应用神经母细胞瘤治疗反应评价标准和美国国立癌症研究所通用不良反应分级标准对化疗近期疗效和相关毒副反应进行评价。结果:27例患儿经术前化疗,总有效率为82%;辅助化疗后24例患儿接受手术治疗,完全切除原发肿瘤14例(58%),部分切除10例(42%)。化疗相关毒副反应主要是骨髓抑制,27例患儿粒细胞下降均为IV级;血红蛋白下降III级7例(26%),IV级20例(74%);血小板下降III级2例(7%),IV级25例(93%)。所有患儿均出现不同程度的感染,经积极的抗感染治疗可以控制。消化道、肝脏、肾脏损害多为Ⅰ、Ⅱ级,经治疗可恢复。2例(7%)出现Ⅰ级神经毒性病例。无心功能受损病例。结论: CDV与CiE联合术前化疗方案治疗IV期神经母细胞瘤有转好的疗效,可为手术治疗创造条件。[中国当代儿科杂志,2009,11(11):885-887]

Abstract

OBJECTIVE: To evaluate the effects and the toxicity of the protocol of CDV combined with CiE as pre-operative chemotherapy in childhood stage IV neuroblastoma. METHODS: The clinical data of 27 children aged from 1.2 to 8 years with neuroblastoma in stage IV was retrospectively studied. The primary sites of the diseases were abdomen (n=21), posterior mediastinum (n=4) and pelvic cavity (n=2). Twenty-three patients had bone marrow metastasis. Twelve patients had bone metastasis. All patients were treated with the CDV protocol (cyclophosphamide+doxorubicin+vincristine) for 3 cycles and the CiE protocol (cisplatin+etoposide) for 2 cycles. Neuroblastoma therapeutic response evaluation criterion and common terminology criteria for adverse events of National Cancer Institute were used to evaluate effects and chemotherapy-related toxicity. RESULTS: All patients received the pre-operative chemotherapy. The overall response rate was 82%. After chemotherapy, 24 patients received operations. Total resection of primary tumor was found in 14 patients (58%) and part resection in 10 patients (42%). The most common chemotherapy-related toxicity was bone marrow suppression: grade IV suppression of neutrophils (n=27), reduction in hemoglobin (III grade, n=7; IV grade, n=20) and reduction in platelet (III grade, n=2; IV grade, n=25). Infection was found in all patients and was controlled with antibiotics.I or II grade lesions of digestive, liver and kidney were found and could be recovered after therapy. Grade I neurotoxicity occurred in 2 patients (7%). The heart function damage was not found in any of patients. CONCLUSIONS: The protocol of CDV combined with CiE as pre-operative chemotherapy might be effective in children with stage IVneuroblastoma.[Chin J Contemp Pediatr, 2009, 11 (11):885-887]

关键词

神经母细胞瘤 / 化疗 / 毒性反应 / 儿童

Key words

Neuroblastoma / Chemotherapy / Toxicity / Child

引用本文

导出引用
冯晨, 唐锁勤, 王建文, 刘英, 杨光. CDV与CiE两种方案联合术前化疗治疗晚期儿童神经母细胞瘤的近期疗效观察[J]. 中国当代儿科杂志. 2009, 11(12): 885-887
FENG Chen, TANG Suo-Qin, WANG Jian-Wen, LIU Ying, YANG Guang. Curative effects of the protocol of CDV combined with CiE as pre-operative chemotherapy in high-risk childhood neuroblastoma[J]. Chinese Journal of Contemporary Pediatrics. 2009, 11(12): 885-887
中图分类号: R739.43   

参考文献

[1]Schwab M, Westermann F, Hero B, Berthold F. Neuroblastoma: biology and molecular and chromosomal pathology[J]. Lancet Oncol, 2003, 4(8):472-480.
[2]Castel V, Tovar JA, Costa E, Cuadros J, Ruiz A, Rollan V, et al. The role of surgery in stage IV neuroblastoma [J]. J Pediatr Surg, 2002, 37(11):1574-1578.
[3]符仁义,刘玉峰.儿童血液与肿瘤疾病[M].郑州:河南科学技术出版社,2005, 367-385.
[4]唐锁勤,黄东生,王建文,冯晨,杨光. 大剂量化疗造血干细胞移植治疗IV期神经母细胞瘤的长期疗效研究[J].中国当代儿科杂志,2006,8(2):93-96.
[5]Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK. Reduction  from  seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma[J]. J Clin Oncol, 2004, 22(24):4888-4892.
[6]McWilliams NB, Hayes FA, Green AA, Smith EI, Nitschke R, Altshuler GA, et al. Cyclophosphamide/doxorubicin vs. cisplatin/teniposide in the treatment of children older than 12 months of age with disseminated neuroblastoma:a Pediatric Oncology Group Randomized Phase II study[J]. Med Pediatr Oncol, 1995, 24(3):176-180.
[7]冯晨,唐锁勤,黄东生,王建文,于芳,杨光. CEM为预处理方案的自体外周血造血干细胞移植治疗晚期神经母细胞瘤相关毒性及疗效观察[J].中国当代儿科杂志,2004,6(6):489-491.
[8]张海娟,吴凤鹏,王运端,李惠敏. 顺铂联合足叶乙甙对卵巢癌SKOV3细胞的增殖抑制作用及机制探讨[J]. 山东医药,2008,48(33):8-9.
[9]Kushner BH, Kramer K, Modak S, Qin LX, Yataghena K, Jhanwar SC,  et al. Reduced risk of secondary leukemia with fewer cycles of doseintensive induction chemotherapy in patients with neuroblastoma[J]. Pediatr Blood Cancer, 2009, 53(1):17-22.
[10]常璇,陆爱梅,潘婷.30 例应用CDV 方案化疗的晚期神经母细胞瘤患儿的护理[J ].现代护理,2007,13(30):2863-2864.


PDF(956 KB)

Accesses

Citation

Detail

段落导航
相关文章

/